< Back to previous page
Researcher
Thomas Vanassche
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From19 Aug 2010 → Today - Cardiology (Division)
Member
From1 Oct 2009 → 18 Aug 2010
Projects
1 - 10 of 13
- Multigene thrombophilia testing in patients with venous thromboembolismFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Mechanical cardiac unloading with micro-axial flow pumps: post-implantation effects on remodelling and bleeding/thrombosisFrom16 Sep 2021 → TodayFunding: FWO fellowships
- Targeting Immunothrombosis in Staphylococcus Aureus Infections and EndocarditisFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Investigating the role of neutrophil extracellular traps in the failing heartFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting Immunothrombosis in Staphylococcus aureus infections and endocarditisFrom1 Oct 2020 → TodayFunding: BOF - projects
- Calming the storm: treating hypercoagulability and hyperinflammation in patients with COVID-19From22 May 2020 → 21 May 2021Funding: FWO thematic call for applied research
- Neutrophil extracellular traps in cardiac fibrosis - Peptidylarginine deiminase 4 and neutrophil extracellular traps in chronic inflammation and cardiac fibrosisFrom1 Oct 2019 → 6 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Thromboinflammation in Cardiovascular DiseasesFrom1 Aug 2019 → 20 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Activation of the contact pathway of coagulation in cardiovascular diseasesFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Other initiatives
Publications
1 - 10 of 176
- Heparin dosing in patients with Impella-supported cardiogenic shock.(2024)
Authors: Thomas Vanassche, Bart Meyns
Pages: 131690 - A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State(2024)
Authors: Tom Hillary, Maya Imbrechts, Thomas Vanassche, Maria Garmyn, Séverine Vermeire
- Thromboinflammation in Cardiovascular Diseases(2023)
Authors: Thomas Vanassche, Christophe Vandenbriele, Peter Verhamme
- Peptidylarginine deiminase 4 and ADAMTS13 activity in Staphylococcus aureus bacteraemia(2023)
Authors: Caroline Martens, Marijke Peetermans, Thomas Vanassche, Peter Verhamme, Marc Jacquemin, Kim Martinod
- The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients(2023)
Authors: Thomas Vanassche, Christophe Vandenbriele, Peter Verhamme
Pages: 497 - 508 - Effect of 24-h blood pressure dysregulations and reduced ocular perfusion pressure in open-angle glaucoma progression(2023)
Authors: Thomas Vanassche, Peter Verhamme
Pages: 1785 - 1792 - Serum proteomic profiling of carotid arteriopathy: A population outcome study(2023)
Authors: Nicholas Cauwenberghs, Thomas Vanassche, Tatiana Kouznetsova
- Prediction of coronary artery disease using urinary proteomics(2023)
Authors: Dongmei Wei, Lucas Van Aelst, Thomas Vanassche, Peter Verhamme, Zhenyu Zhang
Pages: 1537 - 1546 - Neutrophil extracellular traps in cardiac fibrosis - Peptidylarginine deiminase 4 and neutrophil extracellular traps in chronic inflammation and cardiac fibrosis(2023)
Authors: Stijn Van Bruggen, Kim Martinod, Thomas Vanassche
- Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study(2023)
Authors: Thomas Vanassche, Peter Verhamme
Pages: 2929 - 2940